New hope for celiac sufferers: drug targets stubborn symptoms
NCT ID NCT04424927
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called PRV-015 in 388 adults with celiac disease who still had symptoms like belly pain and bloating even after following a strict gluten-free diet. The goal was to see if the drug could reduce these symptoms better than a placebo. Participants took the drug or a placebo for 24 weeks while continuing their gluten-free diet.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Site
Los Angeles, California, 90036, United States
-
Clinical Site
Ventura, California, 93003, United States
-
Clinical Site
Denver, Colorado, 80209, United States
-
Clinical Site
Leesburg, Florida, 34748, United States
-
Clinical Site
Tampa, Florida, 33613, United States
-
Clinical Site
Winter Park, Florida, 32789, United States
-
Clinical Site
Chicago, Illinois, 60637, United States
-
Clinical Site
Boston, Massachusetts, 02111, United States
-
Clinical Site
Chesterfield, Michigan, 48047, United States
-
Clinical Site
Rochester, Minnesota, 55905, United States
-
Clinical Site
Morristown, New Jersey, 07960, United States
-
Clinical Site
New Windsor, New York, 12553, United States
-
Clinical Site
Raleigh, North Carolina, 27607, United States
-
Clinical Site
Philadelphia, Pennsylvania, 19104, United States
-
Clinical Site
Uniontown, Pennsylvania, 14401, United States
-
Clinical Site
Warwick, Rhode Island, 02886, United States
-
Clinical Site
Nashville, Tennessee, 37212, United States
-
Clinical Site
Garland, Texas, 75044, United States
-
Clinical Site
West Jordan, Utah, 84088, United States
-
Clinical Site
Bellevue, Washington, 98004, United States
-
Clinical Site
Tacoma, Washington, 98405, United States
-
Clinical Site
Hamilton, Ontario, L8S4K1, Canada
-
Clinical Site
Amsterdam, 1105 AZ, Netherlands
-
Clinical Site
Seville, Andalusia, 41013, Spain
-
Clinical Site
León, Castille and León, 24071, Spain
-
Clinical Site
Madrid, 28034, Spain
-
Clinical Site
Madrid, 28041, Spain
-
Clinical Site
Madrid, 28222, Spain
-
Clinical Trial Site
Northbrook, Illinois, 60062, United States
-
Clinical Trial Site
Chevy Chase, Maryland, 20815, United States
-
Clinical Trial Site
Brooklyn, New York, 11235, United States
-
Clinical Trial Site
New York, New York, 10032, United States
-
Clinical Trial Site
Dublin, Ohio, 43016, United States
-
Clinical Trial Site
North Charleston, South Carolina, 29405, United States
-
Clinical Trial Site
Cedar Park, Texas, 78613, United States
-
Clinical Trial Site
Terrassa, Catalonia, 082211, Spain
-
Clinical Trial Site
Girona, 17007, Spain
-
Clinical Trial Site
Lleida, 25196, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a lesson in Gluten-Free eating boost Kids' health?
- Wheat sensitivity linked to fatty liver? a new study investigates
- Blood test plus symptom check may spare thousands from celiac biopsy
- Iron infusions may boost gut healing in celiac disease
- Massive spanish study maps celiac disease trends across generations
- Can a home gluten test help heal celiac disease?